The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Kelly James H since year 2005.
The trader's CIK number is 1354557.
At the time of this reporting, Kelly James H is the Chief Executive Officer of Stem Cell Innovations, Inc. .
(stock ticker symbol SCLL.OB).
See this page for all insider trading activities at Stem Cell Innovations, Inc. .
Stock purchases, sales, and option exercises reported by insider Kelly James H since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2008-01-03
SCLL.OB
Stem Cell Innovations, Inc.
Sale
400,000
.01
4,000
2007-12-11
SCLL.OB
Stem Cell Innovations, Inc.
Sale
640,000
.01
8,384
2007-12-12
SCLL.OB
Stem Cell Innovations, Inc.
Sale
115,000
.01
1,437
2007-12-13
SCLL.OB
Stem Cell Innovations, Inc.
Sale
200,000
.01
2,500
2008-03-03
SCLL.OB
Stem Cell Innovations, Inc.
Sale
44,633
.01
580
2007-12-17
SCLL.OB
Stem Cell Innovations, Inc.
Sale
155,000
.01
1,705
2007-12-18
SCLL.OB
Stem Cell Innovations, Inc.
Sale
250,000
.01
2,750
2007-12-19
SCLL.OB
Stem Cell Innovations, Inc.
Sale
180,000
.01
1,979
2007-12-26
SCLL.OB
Stem Cell Innovations, Inc.
Sale
173,486
.01
1,734
2008-01-02
SCLL.OB
Stem Cell Innovations, Inc.
Sale
541,881
.01
5,418
2008-02-29
SCLL.OB
Stem Cell Innovations, Inc.
Sale
8,200,000
.01
90,200
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Kelly James H
(Chief Executive Officer of Stem Cell Innovations, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
